EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieStudienprotokollOpen Access · CC BY 4.0

Using a digital health intervention “INTERCEPT” to improve secondary prevention in coronary heart disease (CHD) patients: protocol for a mixed methods non-randomised feasibility study

Irene Gibson iD, Catriona Jennings, Lis Neubeck iD, Marissa Corcoran iD, David Wood, Faisal Sharif, Lisa Hynes, Andrew W Murphy, Molly Byrne, John William McEvoy

HRB Open Research · 31.01.2025 · 6 · 43

DOI: 10.12688/hrbopenres.13781.2 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift HRB Open Research, online erschienen am 31.01.2025. Verfasst von Irene Gibson und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Galway, Galway, Ireland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Board Ireland Collaborative Doctoral Award 2019, National Institute for Prevention and Cardiovascular Health, Ireland, University of Sydney, Australia SOLVE CHD SYNERGY Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Digital health interventions (DHIs) are increasingly used for the secondary prevention of cardiovascular disease (CVD). The aim of this study is to determine the feasibility of “INTERCEPT”, a co-designed DHI developed to improve secondary prevention in hospitalised coronary heart disease patients (CHD).

Methods

This non-randomised, pilot feasibility study with embedded process evaluation will be conducted with a sample of 40 patients in an acute hospital setting. Informed by behaviour change theory, INTERCEPT integrates a smartphone interface, health care professional portal, a fitness wearable and a blood pressure monitor. INTERCEPT is designed to support and motivate patients to set goals, self-monitor lifestyle and medical risk factors, and manage their medications, with the health care professional portal enabling monitoring and communication with patients. Using consecutive sampling, eligible patients will be recruited in two phases, a pre-implementation phase and an implementation phase. Commencing with pre-implementation (1 month duration), participants will not immediately receive INTERCEPT, however, they will be invited to receive INTERCEPT at 3 months follow-up. This will enable early learning about the processes of recruitment and conducting the assessment prior to full scale deployment of INTERCEPT in the next step implementation phase. During the implementation phase (2 months duration), participants will be invited to download INTERCEPT to their smartphone prior to hospital discharge. Qualitative interviews will be conducted among a subset of patients and health care professionals to gain a greater insight into their experience of using INTERCEPT. Primary outcomes will be assessed at baseline and 3-month follow-up. Using pre-defined feasibility criteria, including recruitment, retention and engagement rates, together with data on intervention acceptability, will determine the appropriateness of progressing to a definitive trial.

Discussion

This study will provide important insights to help inform the feasibility of conducting a definitive trial of “INTERCEPT” among coronary heart disease patients in a critical health care setting.

Schlagwörter

Stichwörter der Autor:innen

Cardiovascular diseaseacceptabilitydigital health interventionsfeasibilitysecondary prevention

Autor:innen und Institutionen

  • School of Medicine, University of Galway, Galway, Ireland.
  • National Institute for Prevention and Cardiovascular Health, Galway, Ireland.
  • School of Health and Social Care, Edinburgh Napier University, Edinburgh, UK.
  • Cardiology Department, St. James's Hospital, Dublin, Ireland.
  • Croí, West of Ireland Cardiac Foundation, Galway, Ireland.
  • Discipline of General Practice, University of Galway, Galway, Ireland.

ORCID-Profile: Irene Gibson, Lis Neubeck, Marissa Corcoran

Förderung

  • Health Research Board Ireland Collaborative Doctoral Award 2019
  • National Institute for Prevention and Cardiovascular Health, Ireland
  • University of Sydney, Australia SOLVE CHD SYNERGY Grant

Zitieren

APA

Gibson, I., Jennings, C., Neubeck, L., Corcoran, M., Wood, D., Sharif, F., Hynes, L., Murphy, A. W., Byrne, M., & McEvoy, J. W. (2025). Using a digital health intervention “INTERCEPT” to improve secondary prevention in coronary heart disease (CHD) patients: protocol for a mixed methods non-randomised feasibility study. HRB Open Research, 6, 43. https://doi.org/10.12688/hrbopenres.13781.2

Vancouver

Gibson I, Jennings C, Neubeck L, Corcoran M, Wood D, Sharif F, et al. Using a digital health intervention “INTERCEPT” to improve secondary prevention in coronary heart disease (CHD) patients: protocol for a mixed methods non-randomised feasibility study. HRB Open Research. 2025;6:43. doi:10.12688/hrbopenres.13781.2

BibTeX
@article{Gibson2025,
  author = {Gibson, Irene and Jennings, Catriona and Neubeck, Lis and Corcoran, Marissa and Wood, David and Sharif, Faisal and Hynes, Lisa and Murphy, Andrew W and Byrne, Molly and McEvoy, John William},
  title = {Using a digital health intervention “INTERCEPT” to improve secondary prevention in coronary heart disease (CHD) patients: protocol for a mixed methods non-randomised feasibility study},
  journal = {HRB Open Research},
  year = {2025},
  volume = {6},
  pages = {43},
  doi = {10.12688/hrbopenres.13781.2}
}
Kostenlos starten →